Case File
efta-efta01015898DOJ Data Set 9OtherFrom: David Fiszel
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01015898
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: David Fiszel
To: Jeffrey Epstein <[email protected]>
Subject: Fwd: SA: TSLA [Tesla reducing price of Model X and S cars in China to absorb hit from tariffs -
Reuters (21-Nov after the close)]
Date: Fri, 23 Nov 2018 15:14:01 +0000
Great seeing you. Perfect example of US companies making the decision to eat it.
Begin forwarded message:
From: StreetAccount
Date: November 23, 2018 at 8:24:13 AM EST
To:
Subject: SA: TSLA ]Tesla reducing price of Model X and S cars in China to absorb hit from tariffs -
Reuters (21-Nov after the close)]
Reply-To:
08:24 ET 11/23/18 [StreetAccount] TSLA Tesla reducing price of Model X and S cars in China to absorb
hit from tariffs - Reuters (21-Nov after the close) ($338.19)
• The company indicated in a statement to Reuters that it would cut the price of the Model X and S cars in
a shift of strategy that would see it take more of an impact from tariffs due to the trade war between the
US and China.
• Tesla will reduce prices by 12%-26% to make the cars more affordable.
Reference Link: Reuters
StreetAccount alert for sector(s):
• Consumer Cyclical: Auto & Truck Manufacturers
Tickers mentioned in/related to this story; follow link for 30-day news history: TSLA
Contact us: reply to this email with questions, comments, or corrections, or call us at 617.261.5200.
This email is confidential and intended solely for the use of the individual to whom it is addressed.
Subscribers are prohibited from disclosing, copying or distributing the contents of this email.
FactSet StreetAccount website: www.streetaccount.com
Copyright (C) 2018 FactSet Research Systems Inc. 601 Merritt 7, Norwalk, CT 06851 1
2470995.636789764013593
This e-mail and any file(s) transmitted with it may contain confidential and/or privileged information. Nothing contained in this e-mail
and/or any file(s) transmitted with it constitutes a solicitation or an offer to buy or sell any securities. Use or disclosure of this e-mail
or any such files by anyone other than a designated addressee is unauthorized. If you are not an intended recipient (or have received
EFTA01015898
this email in error), please notify the sender immediately and delete this e-mail without making a copy. If this e-mail is misdirected,
Honeycomb Asset Management, L.P. and its affiliates do not waive confidentiality or any privilege.
EFTA01015899
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Domain
www.streetaccount.comEmail
[email protected]Phone
2470995Phone
617.261.5200Phone
9764013593Wire Ref
ReferenceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.